Based on the detailed analysis of the patented securitization of the American company of Royalty Pharma, this paper combs the risks existing in the financing of China’s intellectual property securitization and puts forward some suggestions to resolve the financing risks. In this paper, we propose an approach for Credit Risk+ model and analysis of the […]